• Nystatin (Fungicidin): Evidence, Mechanism, and Limits

  2026-10-09

  Nystatin is best understood as an ergosterol-targeting polyene antifungal, while the supplied reovirus study provides a useful boundary case for interpreting claims about antiviral activity. This overview compares the provenance and strength of the available evidence, discusses conceptual research applications, and clarifies why findings from Candida, Aspergillus, and grass carp reovirus models should not be treated as interchangeable.

• Surface-Cleaned Black Phosphorus in AKI

  2026-10-08

  A 2026 Theranostics study reports that surface-cleaned black phosphorus nanosheets reduce oxidation, accumulate in injured kidneys, and modulate the ferroptosis–immune axis in acute kidney injury. The work links labile-iron sequestration with reduced lipid peroxidation, tubular injury, and macrophage inflammatory activation, while remaining preclinical and model-dependent.

• Methyl-β-cyclodextrin: Product Overview

  2026-10-08

  Methyl-β-cyclodextrin (SKU C6939) is an APExBIO-listed research reagent associated with conceptual studies of membrane lipids, cholesterol, and membrane organization. No matched paper evidence is available.

• Estradiol, GPR30, and T-Cell Recovery After Shock

  2026-10-07

  The reference study links hemorrhagic shock-induced immune dysfunction to endoplasmic reticulum stress in splenic CD4+ T lymphocytes and identifies distinct contributions from ERα and GPR30. Its pharmacological evidence supports GPR30 as part of an estrogen-responsive pathway, while also showing why receptor selectivity, model context, and non-genetic validation matter when interpreting G-1 studies.

• Rimonabant (SR141716): Evidence and Research Context

  2026-10-07

  Rimonabant (SR141716) is a selective CB1 receptor antagonist used as a mechanistic probe in endocannabinoid research. This overview distinguishes peer-reviewed evidence from supplier-reported findings, with emphasis on cannabinoid withdrawal, appetite regulation research, obesity research, inflammation, sex-related behavioral differences, and translational limitations. The strongest supplied evidence comes from a 2024 rat study using rimonabant to precipitate withdrawal after exposure to the synthetic cannabinoid WIN 55,212-2; broader appetite and inflammation claims remain more dependent on product-description summaries than on directly supplied primary studies.

• SM-164 and the Next Logic of Cell-Death Translation

  2026-10-06

  SM-164 is a bivalent Smac mimetic that offers translational researchers a mechanistically rich way to interrogate IAP-controlled apoptosis. This article connects vendor-reported SM-164 activity with new insights into necrosome assembly, including the reported balance between RIP1 and RIP3 that governs signal amplification and attenuation. It frames SM-164 as a research perturbation for studying cIAP-1/2, XIAP, TNFα-dependent apoptosis, caspase activation, and possible cross-talk between apoptotic and necroptotic signaling—while distinguishing established findings from testable hypotheses and identifying the limits of cell-line and xenograft evidence.

• JHU-083: Evidence, Applications, and Limitations

  2026-10-06

  JHU-083 is described as a 6-diazo-5-oxo-L-norleucine precursor for investigating glutaminase-dependent metabolism and glutamate biology. This overview separates supplier claims from published evidence, explains its conceptual relevance to experimental cerebral malaria research and glutamate excitotoxicity research, and clarifies why findings from a separate α-amanitin hepatotoxicity study should not be generalized to JHU-083.

• Lassa Virus Spike: pH Changes and Inhibition

  2026-10-05

  Katz et al. map previously unresolved pH-dependent conformational changes in the Lassa virus spike, linking early transmembrane rearrangements with later receptor release and spike opening. Their structural and functional evidence also explains how ARN-75039 antagonizes viral entry, while defining important boundaries for interpreting these findings beyond the studied system.

• TUNEL and Mitochondrial Stress in Glioblastoma

  2026-10-05

  This overview examines how terminal deoxynucleotidyl transferase (TdT) labeling can contextualize apoptosis research in glioblastoma, using a recent study of mitochondrial CAT-tailing as the biological framework. It distinguishes reported findings from interpretation, explains conceptual applications in tissue sections and cultured cells, and evaluates the strengths and limits of TUNEL-based DNA fragmentation detection. The discussion also clarifies why TUNEL positivity is not, by itself, proof of apoptosis or evidence that mitochondrial CAT-tailing directly caused a phenotype.

• Maternal IL-17A and Neonatal GBS Risk

  2026-10-03

  A prospective Moroccan mother–newborn study identifies reduced maternal IL-17A, together with lower IL-1β and IL-4 responses, among GBS-colonized women whose newborns developed invasive disease. The work supports maternal IL-17A as a potential risk-stratification biomarker while showing how cytokine profiling and pathogen-recognition receptor stimulation can connect colonization status with neonatal outcomes.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-10-02

  Connect DNA-fragment labeling with practical apoptosis readouts in tissue sections and cultured cells. This guide translates a hepatoprotective peptide study into a controlled workflow for spatial imaging, flow cytometry, and mechanistic validation.

• CUDC-907: Practical PI3K/HDAC Workflow

  2026-10-01

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle progression, and apoptosis. This guidance uses product-dossier specifications and laboratory workflow recommendations rather than directly matched paper evidence; the compound is for research use only and not for diagnostic, clinical, or therapeutic use.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-09-30

  The reference study identifies CD44 as a metabolic dependency of IDH-mutant leukemia, linking R-2HG-driven signaling to pentose phosphate pathway activation and sustained NADPH production. Its findings support combined metabolic and IDH-directed experiments while clarifying how CD44 may contribute to incomplete responses and resistance.

• Oseltamivir acid: Neuraminidase Workflows

  2026-09-30

  Oseltamivir acid supports mechanism-first influenza antiviral research, from purified neuraminidase assays to infection and oncology cell models. This guide combines practical assay design with a cautious translational lesson from humanized-mouse prodrug research, helping teams separate direct enzyme inhibition from exposure and metabolism effects.

• ARCA Cy3 EGFP mRNA (5-moUTP): Lab Guide

  2026-09-29

  A scenario-based guide to using ARCA Cy3 EGFP mRNA (5-moUTP), SKU R1008, to separate mRNA delivery, translation, and cell-viability effects in mammalian cell assays. The article combines product specifications with practical controls and delivery-system context from recent mRNA research.

8644 records 1/577 page Next 12345 下5页 Last page